{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:30:15Z","timestamp":1790886615531,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1987,9,1]],"date-time":"1987-09-01T00:00:00Z","timestamp":557452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1987,9]]},"DOI":"10.1007\/bf01253604","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T16:49:11Z","timestamp":1111596551000},"page":"295-312","source":"Crossref","is-referenced-by-count":15,"title":["Acetylcholine and affective disorder"],"prefix":"10.1007","volume":"70","author":[{"given":"Sandra S.","family":"Leong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/ajp.141.3.469-a","volume":"141","author":"M Berger","year":"1984","unstructured":"Berger M, Doerr P, van Zerssen D (1984) Physostigmine's influence on DST results. Am J Psychiatry 141: 469?470","journal-title":"Am J Psychiatry"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00005053-196404000-00009","volume":"138","author":"MB Bowers","year":"1964","unstructured":"Bowers MB, Goodman E, Sim VM (1964) Some behavioral changes in man following anticholinesterase administration. J Nerv Ment Dis 138: 383?389","journal-title":"J Nerv Ment Dis"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-38-6-1127","volume":"38","author":"WA Brown","year":"1974","unstructured":"Brown WA, Krieger DT, van Woert MH, Ambani LM (1974) Dissociation of growth hormone and cortisol release following apomorphine. J Clin Endocrinol Metab 38: 1127?1129","journal-title":"J Clin Endocrinol Metab"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(73)90285-7","volume":"1","author":"BJ Carroll","year":"1973","unstructured":"Carroll BJ, Frazer A, Schless A, Mendels J (1973) Cholinergic reversal of manic symptoms. Lancet 1: 427?428","journal-title":"Lancet"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/acps.1980.61.s280.183","volume":"280","author":"BJ Carroll","year":"1980","unstructured":"Carroll BJ, Greden JF, Hasket R, Feinberg M, Albala AA, Martin FIR, Rubin RT, Heath B, Sharp PT, McLeod WL, McLeod MF (1980) Neurotransmitter studies of neuroendocrine pathology in depression. Acta Psychiatr Scand [Suppl] 280: 183?200","journal-title":"Acta Psychiatr Scand [Suppl]"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00427135","volume":"62","author":"DE Casey","year":"1979","unstructured":"Casey DE (1979) Mood alterations during deanol therapy. Psychopharmacology 62: 187?191","journal-title":"Psychopharmacology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1176\/ajp.139.9.1162","volume":"139","author":"BM Cohen","year":"1982","unstructured":"Cohen BM, Lipinski JF, Altesman RI (1982) Lecithin in the treatment of mania: double-blind, placebo-controlled trials. Am J Psychiatry 139: 1162?1164","journal-title":"Am J Psychiatry"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1192\/bjp.141.1.81","volume":"141","author":"J Coid","year":"1982","unstructured":"Coid J, Strang J (1982) Mania secondary to procyclidine (?Kemadrin?) abuse. Br J Psychiatry 141: 81?84","journal-title":"Br J Psychiatry"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/0024-3205(67)90321-9","volume":"6","author":"H Corrodi","year":"1967","unstructured":"Corrodi H, Fuxe K, Hammer W, Sjoqvist F, Ungerstedt U (1967) Oxotremorine and central monoamine neurons. Life Sci 6: 2557?2566","journal-title":"Life Sci"},{"key":"CR10","first-page":"303","volume":"15","author":"BM Davis","year":"1980","unstructured":"Davis BM, Davis KL (1980) Cholinergic mechanisms and anterior pituitary hormone secretion. Biol Psychiatry 15: 303?310","journal-title":"Biol Psychiatry"},{"key":"CR11","first-page":"23","volume":"13","author":"KL Davis","year":"1978","unstructured":"Davis KL, Berger PA (1978) Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis. Biol Psychiatry 13: 23?49","journal-title":"Biol Psychiatry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.1978.01770250121012","volume":"35","author":"KL Davis","year":"1978","unstructured":"Davis KL, Berger PA, Hollister LE, Defraites E (1978) Physostigmine in mania. Arch Gen Psychiatry 35: 119?122","journal-title":"Arch Gen Psychiatry"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1176\/ajp.136.12.1581","volume":"136","author":"KL Davis","year":"1979","unstructured":"Davis KL, Hollister LE, Berger PA (1979) Choline chloride in schizophrenia. Am J Psychiatry 136: 1581?1584","journal-title":"Am J Psychiatry"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0024-3205(77)90258-2","volume":"21","author":"KL Davis","year":"1977","unstructured":"Davis KL, Hollister LE, Goodwin FK, Gordon EK (1977) Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine. Life Sci 21: 933?936","journal-title":"Life Sci"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00429695","volume":"63","author":"KL Davis","year":"1979","unstructured":"Davis KL, Hollister LE, Livesey J, Berger PA (1979) Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders. Psychopharmacology 63: 155?159","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00426316","volume":"51","author":"KL Davis","year":"1976","unstructured":"Davis KL, Hollister LE, Overall J, Johnson A, Train K (1976) Physostigmine: effects on cognition and affect in normal subjects. Psychopharmacology 51: 23?27","journal-title":"Psychopharmacology"},{"key":"CR17","first-page":"1363","volume":"18","author":"SI Deutsch","year":"1983","unstructured":"Deutsch SI, Mohs RC, Levy MI, Rothpearl AB, Stockton D, Horvath T, Coco A, Davis KL (1983) Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease, and normals. Biol Psychiatry 18: 1363?1373","journal-title":"Biol Psychiatry"},{"key":"CR18","first-page":"97","volume":"78","author":"E El-Fakahany","year":"1983","unstructured":"El-Fakahany E, Richelson E (1983) Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain. Br J Pharmacol 78: 97?102","journal-title":"Br J Pharmacol"},{"key":"CR19","first-page":"304","volume":"3","author":"DC English","year":"1962","unstructured":"English DC (1962) Reintegration of affect and psychic emergence with Ditran. J Neuropsychiatry 3: 304?310","journal-title":"J Neuropsychiatry"},{"key":"CR20","first-page":"53","volume":"49","author":"T Eversmann","year":"1978","unstructured":"Eversmann T, Gottsmann M, Uhlich E, Ulbrecht G, von Werder K, Scriba PC (1978) Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness. Aviat Space Environ Med 49: 53?57","journal-title":"Aviat Space Environ Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(61)92004-9","volume":"1","author":"S Gershon","year":"1961","unstructured":"Gershon S, Shaw FH (1961) Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet 1: 1371?1374","journal-title":"Lancet"},{"key":"CR22","first-page":"363","volume":"1","author":"A Gisselmann","year":"1975","unstructured":"Gisselmann A, Marin A, Simon P (1975) \ufffdtude pilote des effets d'un antiparkinsonien anticholinergique au cours d'etats depressifs. L'Encephale 1: 363?366","journal-title":"L'Encephale"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1476-5381.1980.tb14570.x","volume":"68","author":"PR Golds","year":"1980","unstructured":"Golds PR, Przyslo FR, Strange PG (1980) The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors. Br J Pharmacol 68: 541?549","journal-title":"Br J Pharmacol"},{"key":"CR24","first-page":"186","volume":"18","author":"I Hanin","year":"1982","unstructured":"Hanin I, Cohen BM, Kopp U, Lipinski JF (1982) Erythrocyte and plasma choline in bipolar psychiatric patients: a follow-up study. Psychopharmacol Bull 18: 186?190","journal-title":"Psychopharmacol Bull"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0165-1781(80)90065-7","volume":"3","author":"I Hanin","year":"1980","unstructured":"Hanin I, Kopp U, Spiker DG, Neil JF, Shaw DH, Kupfer DJ (1980) RBC and plasma choline levels in control and depressed individuals: a critical evaluation. Psychiatry Res 3: 345?355","journal-title":"Psychiatry Res"},{"key":"CR26","first-page":"279","volume":"6","author":"JA Hobson","year":"1976","unstructured":"Hobson JA, McCarley RW, McKenna TM (1976) Cellular evidence bearing on the pontine brain-stem hypothesis of desynchronized sleep control. Prog Neurobiol 6: 279?358","journal-title":"Prog Neurobiol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1476-5381.1980.tb10947.x","volume":"71","author":"DK Hyslop","year":"1980","unstructured":"Hyslop DK, Taylor DP (1980) The interaction of trazodone with rat brain muscarinic cholinoceptors. BrJ Pharmacol 71: 359?361","journal-title":"BrJ Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006842-197405000-00008","volume":"36","author":"DS Janowsky","year":"1974","unstructured":"Janowsky DS, El-Yopusef MK, Davis JM (1974) Acetylcholine and depression. Psychosom Med 36: 248?257","journal-title":"Psychosom Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","volume":"1","author":"DS Janowsky","year":"1972","unstructured":"Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergicadrenergic hypothesis of mania and depression. Lancet 1: 632?635","journal-title":"Lancet"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.1973.01750340072012","volume":"28","author":"DS Janowsky","year":"1973","unstructured":"Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1973) Parasympathetic suppression of manic symptoms by physostigmine. Arch Gen Psychiatry 28: 542?547","journal-title":"Arch Gen Psychiatry"},{"key":"CR31","first-page":"129","volume":"17","author":"DS Janowsky","year":"1981","unstructured":"Janowsky DS, Risch SC, Judd LL, Huey LY, Parker DC (1981) Cholinergic supersensitivity in affect disorder patients: behavioral and neuroendocrine observations. Psychopharmacol Bull 17: 129?132","journal-title":"Psychopharmacol Bull"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00310619","volume":"89","author":"DS Janowsky","year":"1986","unstructured":"Janowsky DS, Risch SC, Kennedy B, Ziegler M, Huey L (1986) Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release. Psychopharmacology 89: 150?154","journal-title":"Psychopharmacology"},{"key":"CR33","first-page":"29","volume":"16","author":"DS Janowsky","year":"1980","unstructured":"Janowsky DS, Risch C, Parker D, Huey L, Judd L (1980) Increased vulnerability to cholinergic stimulation in affective-disorder patients. Psychopharmacol Bull 16: 29?31","journal-title":"Psychopharmacol Bull"},{"key":"CR34","unstructured":"Jimerson DS, Nurnberger JI, Simmons S, Gershon ES (1982) Anticholinergic treatment for depression. Presented at the 1982 American psychiatric association meeting, Toronto, Canada"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1073\/pnas.77.10.6144","volume":"77","author":"RS Jope","year":"1980","unstructured":"Jope RS, Jenden DJ, Ehrlich BE, Diamond JM, Gosenfeld LF (1980) Erythrocyte choline concentrations are elevated in manic patients. Proc Natl Acad Sci USA 77: 6144?6146","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-1019597","volume":"14","author":"S Kasper","year":"1981","unstructured":"Kasper S, Moises HW, Bechmann H (1981) The anticholinergic biperiden in depressive disorders. Pharmacopsychiatry 14: 195?198","journal-title":"Pharmacopsychiatry"},{"key":"CR37","first-page":"759","volume":"24","author":"R Lavery","year":"1965","unstructured":"Lavery R, Sharman DF (1965) Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline, and 5-hydroxytryptamine in the brain. Br J Pharmacol 24: 759?772","journal-title":"Br J Pharmacol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/ajp.139.1.125","volume":"139","author":"RJ Mathew","year":"1982","unstructured":"Mathew RJ, Ho BT, Khan MM, Perales C, Weinman ML, Claghorn JL (1982) True and pseudo cholinesterases in depression. Am J Psychiatry 139: 125?127","journal-title":"Am J Psychiatry"},{"key":"CR39","first-page":"20","volume":"1","author":"LJ Meduna","year":"1959","unstructured":"Meduna LJ, Abood LG (1959) Studies of a new drug (Ditran) in depressive states. J Neuropsychiatry 1: 20?22","journal-title":"J Neuropsychiatry"},{"key":"CR40","first-page":"197","volume":"36","author":"M Milstoc","year":"1975","unstructured":"Milstoc M, Teodoru CV, Fieve RR, Kumbaraci T (1975) Cholinesterase activity and the manic depressive patients. Dis Nerv Sys 36: 197?199","journal-title":"Dis Nerv Sys"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00347089","volume":"218","author":"J Modestin","year":"1973","unstructured":"Modestin J, Hunger J, Schwartz RB (1973) \ufffdber die depressogene Wirkung von Physostigmin. Arch Psychiatrie Nervenkr 218: 67?77","journal-title":"Arch Psychiatrie Nervenkr"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archpsyc.1974.01760110083010","volume":"30","author":"JB Morris","year":"1974","unstructured":"Morris JB, Beck AT (1974) The efficacy of antidepressant drugs. Arch Gen Psychiatry 30: 667?674","journal-title":"Arch Gen Psychiatry"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-1781(83)90043-4","volume":"9","author":"JI Nurnberger","year":"1983","unstructured":"Nurnberger JI, Jimerson DC, Simmons-Alling S, Tamminga C, Nadi NS, Lawrence D, Sitaram N, Gillin JC, Gershon ES (1983) Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and ?well state? bipolar patients. Psychiatry Res 9: 191?200","journal-title":"Psychiatry Res"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-3956(79)90024-4","volume":"15","author":"G Oppenheim","year":"1979","unstructured":"Oppenheim G, Ebstein RP, Belmaker RH (1979) Effect of lithium on the physostigmine induced behavioral syndrome and plasma cyclic GMP. J Psychiatr Res 15: 133","journal-title":"J Psychiatr Res"},{"key":"CR45","first-page":"1071","volume":"17","author":"SC Risch","year":"1982","unstructured":"Risch SC (1982) Beta-endorphin hypersecretion in depression: possible cholinergic mechanisms. Biol Psychiatry 17: 1071?1079","journal-title":"Biol Psychiatry"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.7433977","volume":"209","author":"SC Risch","year":"1980","unstructured":"Risch SC, Cohen RM, Janowsky DS, Kalin NH, Murphy DL (1980) Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol. Science 209: 1545?1546","journal-title":"Science"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(81)90012-3","volume":"4","author":"SC Risch","year":"1981","unstructured":"Risch SC, Cohen RM, Janowsky DS, Kalin NH, Sitaram N, Gillin JC, Murphy DL (1981) Physostigmine induction of depressive symptomatology in normal human subjects. Psychiatry Res 4: 89?94","journal-title":"Psychiatry Res"},{"key":"CR48","first-page":"792","volume":"1","author":"RA Robinson","year":"1961","unstructured":"Robinson RA (1961) L'utilisation de l'orphenadrine chez les patients psychiatriques ages. Ann Med Psychol 1: 792","journal-title":"Ann Med Psychol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jnnp.13.1.47","volume":"13","author":"DW Rowntree","year":"1950","unstructured":"Rowntree DW, Nevin S, Wilson A (1950) The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis. J Neurol Neurosurg Psychiatry 13: 47?59","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/cpt1969104522","volume":"10","author":"T Sagales","year":"1969","unstructured":"Sagales T, Erill S, Domino EF (1969) Differential effects of scopolamine and chlorpromazine on REM and NREM sleep in normal male subjects. Clin Pharmacol Ther 10: 522?529","journal-title":"Clin Pharmacol Ther"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/cpt1975186727","volume":"18","author":"T Sagales","year":"1975","unstructured":"Sagales T, Erill S, Domino EF (1975) Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers. Clin Pharmacol Ther 18: 727?732","journal-title":"Clin Pharmacol Ther"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.1984.tb02818.x","volume":"42","author":"RD Schwartz","year":"1984","unstructured":"Schwartz RD, Lehmann J, Kellar KJ (1984) Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain. J Neurochem 42: 1495?1498","journal-title":"J Neurochem"},{"key":"CR53","first-page":"925","volume":"15","author":"N Sitaram","year":"1980","unstructured":"Sitaram N, Gillin JC (1980) Development and use of pharmacological probes of the CNS in man: evidence of cholinergic abnormality in primary affective illness. Biol Psychiatry 15: 925?955","journal-title":"Biol Psychiatry"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.7361118","volume":"208","author":"N Sitaram","year":"1980","unstructured":"Sitaram N, Nurnberger JI, Gershon ES, Gillin JC (1980) Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. Science 208: 200?202","journal-title":"Science"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.176724","volume":"191","author":"N Sitaram","year":"1976","unstructured":"Sitaram N, Wyatt RJ, Dawson S, Gillin JC (1976) REM sleep induction by physostigmine infusion during sleep. Science 191: 1281?1283","journal-title":"Science"},{"key":"CR56","first-page":"351","volume":"41","author":"JM Smith","year":"1980","unstructured":"Smith JM (1980) Abuse of the antiparkinson drugs: a review of the literature. J Clin Psychiatry 41: 351?354","journal-title":"J Clin Psychiatry"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archpsyc.1977.01770140126014","volume":"34","author":"SH Snyder","year":"1977","unstructured":"Snyder SH, Yamamura HI (1977) Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry 34: 236?239","journal-title":"Arch Gen Psychiatry"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(76)90562-6","volume":"2","author":"C Tamminga","year":"1976","unstructured":"Tamminga C, Smith RC, Chang S, Haraszti JS, Davis JM (1976) Depression associated with oral choline. Lancet 2: 905","journal-title":"Lancet"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0306-3623(81)90097-5","volume":"12","author":"DP Taylor","year":"1981","unstructured":"Taylor DP, Hyslop DK, Becker JA (1981) Trazodone does not competitively inhibit binding at muscarinic cholinoceptors. Gen Pharmacol 12: 391?392","journal-title":"Gen Pharmacol"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1019569","volume":"14","author":"G Ungvari","year":"1981","unstructured":"Ungvari G, Karczag I, Gerevich J (1981) Petho: clinical notes on the possible anticholinergic reversal of depressive syndromes. Pharmacopsychiatry 14: 71?73","journal-title":"Pharmacopsychiatry"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1176\/ajp.125.11.1600","volume":"125","author":"GE Vaillant","year":"1969","unstructured":"Vaillant GE (1969) Clinical significance of anticholinergic effects of imipramine-like drugs. Am J Psychiatry 125: 154?156","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01253604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01253604\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01253604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T10:51:53Z","timestamp":1556794313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01253604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":61,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["BF01253604"],"URL":"https:\/\/doi.org\/10.1007\/bf01253604","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,9]]}}}